Cargando…
MicroRNA‐661 modulates redox and metabolic homeostasis in colon cancer
Cancer cell survival and metastasis are dependent on metabolic reprogramming that is capable of increasing resistance to oxidative and energetic stress. Targeting these two processes can be crucial for cancer progression. Herein, we describe the role of microRNA‐661 (miR661) as epigenetic regulator...
Autores principales: | Gómez de Cedrón, Marta, Acín Pérez, Rebeca, Sánchez‐Martínez, Ruth, Molina, Susana, Herranz, Jesús, Feliu, Jaime, Reglero, Guillermo, Enríquez, Jose Antonio, Ramírez de Molina, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709620/ https://www.ncbi.nlm.nih.gov/pubmed/28981199 http://dx.doi.org/10.1002/1878-0261.12142 |
Ejemplares similares
-
A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy
por: Sánchez-Martínez, Ruth, et al.
Publicado: (2015) -
The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance
por: Fernández, Lara P., et al.
Publicado: (2018) -
The transcriptional and mutational landscapes of lipid metabolism-related genes in colon cancer
por: Fernández, Lara P., et al.
Publicado: (2017) -
3’UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients
por: Vargas, Teodoro, et al.
Publicado: (2016) -
ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone
por: Aguirre‐Portolés, Cristina, et al.
Publicado: (2018)